Pharmacology

Action Mechanism of Action Reference
INHIBITOR Tumor necrosis factor ligand superfamily member 4 inhibitor

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Dermatitis, Atopic 3 D003876 ClinicalTrials
Eczema 2 D004485 ClinicalTrials
Asthma 2 D001249 ClinicalTrials
Alopecia Areata 2 D000506 ClinicalTrials
Hidradenitis 2 D016575 ClinicalTrials
Immune System Diseases 1 D007154 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4594569
FDA SRS YZ6BH6TN8P